Aspergillus species intrinsically resistant to antifungal agents.
about
Aspergillus felis sp. nov., an emerging agent of invasive aspergillosis in humans, cats, and dogsAspergillus nidulans and chronic granulomatous disease: a unique host-pathogen interactionTriazole Resistance in Aspergillus Species: An Emerging Problem.Clinical implications of globally emerging azole resistance in Aspergillus fumigatus.First detection of TR46/Y121F/T289A and TR34/L98H alterations in Aspergillus fumigatus isolates from azole-naive patients in Denmark despite negative findings in the environment.Cryptic and rare Aspergillus species in Brazil: prevalence in clinical samples and in vitro susceptibility to triazoles.Are we there yet? Recent progress in the molecular diagnosis and novel antifungal targeting of Aspergillus fumigatus and invasive aspergillosis.MALDI-TOF mass spectrometry: any use for Aspergilli?Aspergillus versicolor, a new causative agent of canine disseminated aspergillosisAspergillus and aspergilloses in wild and domestic animals: a global health concern with parallels to human disease.Aspergillus tubingensis: a major filamentous fungus found in the airways of patients with lung disease.Molecular identification and amphotericin B susceptibility testing of clinical isolates of Aspergillus from 11 hospitals in Korea.In Vitro Antifungal Activities against Moulds Isolated from Dermatological Specimens.Efficacy and safety of current drug therapies for invasive aspergillosis.Infections associated with chronic granulomatous disease: linking genetics to phenotypic expression.Current status of antifungal resistance and its impact on clinical practice.Exploring azole antifungal drug resistance in Aspergillus fumigatus with special reference to resistance mechanisms.Evaluation of mRNA Expression Levels of cyp51A and mdr1, Candidate Genes for Voriconazole Resistance in Aspergillus flavus.Diagnostic of Fungal Infections Related to Biofilms.Time-Kill Kinetics and In Vitro Antifungal Susceptibility of Non-fumigatus Aspergillus Species Isolated from Patients with Ocular Mycoses.One-health pathogens in the Aspergillus viridinutans complex.Role of Aspergillus lentulus 14-α sterol demethylase (Cyp51A) in azole drug susceptibility.Animal Models for Studying Triazole Resistance in Aspergillus fumigatus.Prospective multicenter international surveillance of azole resistance in Aspergillus fumigatus.Genetic validation and spectroscopic detailing of DHN-melanin extracted from an environmental fungus.Ergosterol biosynthesis in Aspergillus fumigatus: its relevance as an antifungal target and role in antifungal drug resistance.Aspergillus fumigatus morphology and dynamic host interactions.Aspergillosis in Chronic Granulomatous Disease.The high-osmolarity glycerol- and cell wall integrity-MAP kinase pathways of Saccharomyces cerevisiae are involved in adaptation to the action of killer toxin HM-1.Amphotericin B in vitro resistance is associated with fatal Aspergillus flavus infection.[Differential diagnosis for detection of hyphae in tissue].Azole Resistance in Aspergillus fumigatus: Mechanisms, Route of Resistance Selection, and Clinical ImplicationsAzole-Resistant Invasive Aspergillosis: Relationship to Agriculture
P2860
Q21133504-1CFCCA8F-A14E-4904-9F3F-F233EED8CD9CQ26864717-EA914B8E-A72F-4861-81D6-4FD362AF08AEQ30235566-B2F08985-85CE-4E01-B901-8C996CA5B329Q30239051-E17BA063-602E-4413-94EF-63EC9EEBF2F0Q34057414-C37F666F-B18E-4573-8250-757B0442F477Q34298083-9ABE670A-8A70-49DD-8FAF-01A9CA8B9CD8Q35034171-6C86392B-81AE-4D76-999F-1CB9BB57B15EQ35202737-9A08060A-D413-4945-A32D-19C501268164Q35668302-69ED5C24-2C5E-4866-84EA-4B6A29E6A485Q35758334-F8BF16F1-0CEE-4F12-B32B-976691A6EFF5Q35895718-C63C9777-2997-4487-AA9A-FC6F5BCAEA00Q36083696-2FCF3E01-32CE-41D5-80F2-0567739E094CQ37069725-9E632AFB-CE17-4A4D-9B0D-003D31ABDBD0Q37944001-E8E7DB34-7366-466C-8B7A-188E68FE150DQ38048847-CA1BE08E-DB20-4DC1-9182-6B72FDCF3F9EQ38205859-59DA4406-9180-4DD6-BB80-158509DDB7F3Q38222570-6DC43364-5EFE-49F7-A7FC-C07B7DA0825CQ38282758-1D624A80-F0C7-474D-9BCF-1F3083773B50Q38853348-8D75D775-7212-4A2C-A8DC-506F6943152BQ38914243-69D9BC26-D449-4721-9265-EEDA783077B8Q39221749-BF106722-B2DF-4BED-9D65-642030BA0414Q39659834-2F2C886B-02D0-4DBB-9FBC-A3F10FB348FCQ40045642-9DDEB580-FB98-4332-A961-0824F1CC49DBQ41542809-6A474140-019F-45C9-8306-5B0294C3693DQ41682034-F86EA819-3B23-43EA-8A91-C84731979BC5Q41874270-6E7FC426-8F9E-453A-9908-F5664E761DB2Q41997165-0C0B7BC8-F6A7-4AA6-9112-EBC705D4B676Q47645142-6972214B-2170-45DC-8D0F-1D058D682047Q50501910-6AA78661-D167-43D3-8679-5D43DF0D19A6Q51367866-4C539B94-AE9E-413A-AD4E-3A97717756F9Q52882070-DE1C4986-00B0-45FB-93C5-2AB93AF639F1Q56993256-B5AE1CAA-C76D-42E6-A1B5-4A7B75F12009Q57650487-D4A55C2B-324A-461A-AED9-9EA7C02FC08C
P2860
Aspergillus species intrinsically resistant to antifungal agents.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 22 July 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Aspergillus species intrinsically resistant to antifungal agents.
@en
Aspergillus species intrinsically resistant to antifungal agents.
@nl
type
label
Aspergillus species intrinsically resistant to antifungal agents.
@en
Aspergillus species intrinsically resistant to antifungal agents.
@nl
prefLabel
Aspergillus species intrinsically resistant to antifungal agents.
@en
Aspergillus species intrinsically resistant to antifungal agents.
@nl
P1433
P1476
Aspergillus species intrinsically resistant to antifungal agents
@en
P2093
Jan W M Van Der Linden
P356
10.3109/13693786.2010.499916
P478
49 Suppl 1
P577
2010-07-22T00:00:00Z